Investor Relations

For press releases prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc. (known as Innoviva, Inc. since January 7, 2016), please visit Innoviva, Inc. Investor Relations Press Releases.


Press Releases
Date Title and Summary View
May 16, 2016 DUBLIN, IRELAND -- (Marketwired) -- 05/16/16 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that results from post hoc analyses of ...
May 11, 2016 DUBLIN, IRELAND -- (Marketwired) -- 05/11/16 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that new data on VIBATIV® (telavan...
May 9, 2016 DUBLIN, IRELAND -- (Marketwired) -- 05/09/16 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today reported financial results for the first quarter...
May 9, 2016 DUBLIN, IRELAND -- (Marketwired) -- 05/09/16 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that the U.S. Food and Drug Administra...
May 6, 2016 DUBLIN, IRELAND -- (Marketwired) -- 05/06/16 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") announced today that stock options to purchase an aggre...
May 4, 2016 DUBLIN, IRELAND -- (Marketwired) -- 05/04/16 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) today announced that it has closed the sale of its previously announced underwritten public offe...
May 2, 2016 DUBLIN, IRELAND -- (Marketwired) -- 05/02/16 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that it will release financial results...
Apr 29, 2016 DUBLIN, IRELAND -- (Marketwired) -- 04/29/16 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) today announced the pricing of an underwritten public offering of 4,765,000 ordinary shares at a...
Apr 27, 2016 DUBLIN, IRELAND -- (Marketwired) -- 04/27/16 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) today announced that it intends to offer, subject to market conditions, 4,250,000 ordinary share...
Apr 11, 2016 DUBLIN, IRELAND -- (Marketwired) -- 04/11/16 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that new positive data from a study of...
1
... NextLast
Add to Briefcase = add release to Briefcase
By clicking on the link below, you will leave www.theravance.com.
CancelContinue
Form content here please :)